NLRP3 and infection: Inhibition of the NLRP3 inflammasome by CVL may reduce the pathogenic effects induced by the metabolic danger signals, and the side effects of NLRP3 inflammasome inhibition (e.g., increased susceptibility to infection) can be compensated for by other inflammasomes (34).